Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1973 1
1974 2
1976 2
1977 5
1978 5
1979 5
1980 3
1981 5
1982 9
1983 9
1984 10
1985 7
1986 15
1987 8
1988 9
1989 14
1990 12
1991 12
1992 12
1993 9
1994 13
1995 9
1996 13
1997 11
1998 15
1999 10
2000 15
2001 14
2002 22
2003 29
2004 36
2005 52
2006 45
2007 48
2008 44
2009 58
2010 73
2011 83
2012 113
2013 127
2014 115
2015 106
2016 124
2017 139
2018 167
2019 196
2020 247
2021 329
2022 333
2023 307
2024 202

Text availability

Article attribute

Article type

Publication date

Search Results

2,913 results

Results by year

Filters applied: . Clear all
Page 1
Kidney fibrosis: from mechanisms to therapeutic medicines.
Huang R, Fu P, Ma L. Huang R, et al. Among authors: fu p. Signal Transduct Target Ther. 2023 Mar 17;8(1):129. doi: 10.1038/s41392-023-01379-7. Signal Transduct Target Ther. 2023. PMID: 36932062 Free PMC article. Review.
Metabolic reprogramming, oxidative stress, and pulmonary hypertension.
Pokharel MD, Marciano DP, Fu P, Franco MC, Unwalla H, Tieu K, Fineman JR, Wang T, Black SM. Pokharel MD, et al. Among authors: fu p. Redox Biol. 2023 Aug;64:102797. doi: 10.1016/j.redox.2023.102797. Epub 2023 Jun 24. Redox Biol. 2023. PMID: 37392518 Free PMC article. Review.
Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria.
Lv J, Liu L, Hao C, Li G, Fu P, Xing G, Zheng H, Chen N, Wang C, Luo P, Xie D, Zuo L, Li R, Mao Y, Dong S, Zhang P, Zheng H, Wang Y, Qin W, Wang W, Li L, Jiao W, Fang J, Zhang H. Lv J, et al. Among authors: fu p. Kidney Int Rep. 2022 Dec 29;8(3):499-506. doi: 10.1016/j.ekir.2022.12.014. eCollection 2023 Mar. Kidney Int Rep. 2022. PMID: 36938094 Free PMC article.
lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1.
Zhang Z, Lu YX, Liu F, Sang L, Shi C, Xie S, Bian W, Yang JC, Yang Z, Qu L, Chen SY, Li J, Yang L, Yan Q, Wang W, Fu P, Shao J, Li X, Lin A. Zhang Z, et al. Among authors: fu p. Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2206694120. doi: 10.1073/pnas.2206694120. Epub 2023 Feb 16. Proc Natl Acad Sci U S A. 2023. PMID: 36795754 Free PMC article.
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Jiang Z, Ouyang Q, Sun T, Zhang Q, Teng Y, Cui J, Wang H, Yin Y, Wang X, Zhou X, Wang Y, Sun G, Wang J, Zhang L, Yang J, Qian J, Yan M, Liu X, Yi T, Cheng Y, Li M, Zang A, Wang S, Wang C, Wu X, Cheng J, Li H, Lin Y, Geng C, Gu K, Xie C, Xiong H, Wu X, Yang J, Li Q, Chen Y, Li F, Zhang A, Zhang Y, Wu Y, Nie J, Liu Q, Wang K, Mo X, Chen L, Pan Y, Fu P, Zhang H, Pang D, Sheng Y, Han Y, Wang H, Cang S, Luo X, Yu W, Deng R, Yang C, Keegan P. Jiang Z, et al. Among authors: fu p. Nat Med. 2024 Jan;30(1):249-256. doi: 10.1038/s41591-023-02677-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191615 Clinical Trial.
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
Wu J, Jiang Z, Liu Z, Yang B, Yang H, Tang J, Wang K, Liu Y, Wang H, Fu P, Zhang S, Liu Q, Wang S, Huang J, Wang C, Wang S, Wang Y, Zhen L, Zhu X, Wu F, Lin X, Zou J. Wu J, et al. Among authors: fu p. BMC Med. 2022 Dec 27;20(1):498. doi: 10.1186/s12916-022-02708-3. BMC Med. 2022. PMID: 36575513 Free PMC article. Clinical Trial.
2,913 results